ALS patients frequently harbor mutations in the vascular endothelial growth factor (VEGF) gene; (motor cortical) protein expression and VEGF serum levels are reduced in ALS rodent models and patients [58,59,60]. The gene discussed is VEGFA; the disease is amyotrophic lateral sclerosis.